AU2002232061A1 - Compositions having improved bioavailability of eletriptan - Google Patents
Compositions having improved bioavailability of eletriptanInfo
- Publication number
- AU2002232061A1 AU2002232061A1 AU2002232061A AU2002232061A AU2002232061A1 AU 2002232061 A1 AU2002232061 A1 AU 2002232061A1 AU 2002232061 A AU2002232061 A AU 2002232061A AU 2002232061 A AU2002232061 A AU 2002232061A AU 2002232061 A1 AU2002232061 A1 AU 2002232061A1
- Authority
- AU
- Australia
- Prior art keywords
- eletriptan
- compositions
- improved bioavailability
- bioavailability
- improved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0105131.7 | 2001-03-01 | ||
GBGB0105131.7A GB0105131D0 (en) | 2001-03-01 | 2001-03-01 | Compositions having improved bioavailability |
PCT/IB2002/000512 WO2002070070A2 (en) | 2001-03-01 | 2002-02-20 | Compositions having improved bioavailability of eletriptan |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002232061A1 true AU2002232061A1 (en) | 2002-09-19 |
Family
ID=9909814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002232061A Abandoned AU2002232061A1 (en) | 2001-03-01 | 2002-02-20 | Compositions having improved bioavailability of eletriptan |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1372785A2 (en) |
JP (1) | JP2004529893A (en) |
AU (1) | AU2002232061A1 (en) |
BR (1) | BR0207751A (en) |
CA (1) | CA2439917A1 (en) |
GB (1) | GB0105131D0 (en) |
MX (1) | MXPA03007836A (en) |
WO (1) | WO2002070070A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004089365A1 (en) * | 2003-04-11 | 2004-10-21 | Pfizer Limited | Pharmaceutical combination comprising eletriptan and sodium bicarbonate |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9709739D0 (en) * | 1997-05-14 | 1997-07-02 | Merck Sharp & Dohme | Pharmaceutical formulation |
US6255334B1 (en) * | 1998-10-30 | 2001-07-03 | Pfizer Inc | 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
-
2001
- 2001-03-01 GB GBGB0105131.7A patent/GB0105131D0/en not_active Ceased
-
2002
- 2002-02-20 WO PCT/IB2002/000512 patent/WO2002070070A2/en not_active Application Discontinuation
- 2002-02-20 EP EP02712162A patent/EP1372785A2/en not_active Withdrawn
- 2002-02-20 BR BR0207751-5A patent/BR0207751A/en not_active IP Right Cessation
- 2002-02-20 CA CA002439917A patent/CA2439917A1/en not_active Abandoned
- 2002-02-20 AU AU2002232061A patent/AU2002232061A1/en not_active Abandoned
- 2002-02-20 JP JP2002569239A patent/JP2004529893A/en active Pending
- 2002-02-20 MX MXPA03007836A patent/MXPA03007836A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2439917A1 (en) | 2002-09-12 |
GB0105131D0 (en) | 2001-04-18 |
EP1372785A2 (en) | 2004-01-02 |
MXPA03007836A (en) | 2003-12-08 |
JP2004529893A (en) | 2004-09-30 |
BR0207751A (en) | 2004-03-09 |
WO2002070070A2 (en) | 2002-09-12 |
WO2002070070A3 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002363005A1 (en) | Derivatives of uk-2a | |
AU2002313236A1 (en) | Medicinal compositions | |
AU2002349297A1 (en) | Statin-like compounds | |
AU2002359165A1 (en) | Novel compounds | |
AU2002361149A1 (en) | Set of teeth | |
AU2002347377A1 (en) | Sustained-release compositions | |
AU2002359026A1 (en) | Compositon of dentifrice | |
AU2002365093A1 (en) | Therapeutic compositions | |
AUPR600601A0 (en) | Therapeutic compositions | |
AU2002341901A1 (en) | Novel compositions of carvedilol | |
AU2002232061A1 (en) | Compositions having improved bioavailability of eletriptan | |
AUPR920301A0 (en) | Neurologically-active compounds | |
AU2002350154A1 (en) | Preparation of polyethylene | |
AU2002346223A1 (en) | Medicinal compositions | |
AU2002359898A1 (en) | Preparation of alpha-diimines | |
AU2002338934A1 (en) | Preparation of benzosuberonylpiperidine compounds | |
AU2002317699A1 (en) | Improved synthesis of allofuranose | |
AU2002300773A1 (en) | Preparation of Dialkylpyridylboranes | |
AU2002351839A1 (en) | Solid oral compositions | |
AU2002320806A1 (en) | Compositions | |
AUPR971001A0 (en) | Compositions | |
AU2002302710A1 (en) | Magnesium-enriched compositions | |
AU2002315611A1 (en) | Fabric-cleaning compositions | |
AU2002338063A1 (en) | Compositions for potentiating glutatthione | |
AU2004201666B2 (en) | 4-Imidazolin-2-one compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |